Survey: Challenges in Polymorphism and Crystallisation 2011
Contributor:
Pharma IQ Surveys
Posted: 10/21/2011 12:00:00 AM EDT | 0
Posted: 10/21/2011 12:00:00 AM EDT | 0
|
Pharma IQ has put together this short 7 question survey to find out the top challenges in polymorphism and crystallisation that the industry faces. Take part to share your professional opinion on the topic:
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
-
Global ADME – Toxicology Testing Market Update -
Development, Commercialisation and Use of Immunotherapeutic Products -
Generic Market in the US Set For Growth -
A New Pharmaceutial Logistics Paradigm for the Middle East -
Polymorphism and Crystallisation in Modern Pharmaceuticals -
57.1% of Biomanufacturing Firms to Focus on Development of Single Use Systems in 2012 -
Mitigating the Risks of Contamination in Biopharma -
Portuguese Hospitals Block Access to New Medicines as Retail Drug Sector Expected to Meet Savings Goal -
Opportunities and Challenges for New Chinese GMP Compliance -
The SAT-EU Survey on Attitudes Towards Trial Site Selection in Europe
* = required.
Not a member yet? Sign up
You Should Check Out:
Events of Interest




Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!